Lipid-lowering therapy in HIV-infected patients: relationship with antiretroviral agents and impact of substance-related disorders

BACKGROUND: The use of combination antiretroviral therapy (cART) has significantly decreased the morbidity and mortality associated with HIV infection. Lipid disorders, including lipodystrophy, hypertriglyceridemia, hypercholesterolemia, and dyslipidemia, remain the most commonly reported metabolic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Curr Vasc Pharmacol
Prif Awduron: Bednasz, Cindy, Zingman, Barry S., Luque, Amneris E., Fischl, Margaret A., Gripshover, Barbara M., Venuto, Charles S., Gu, Jie, Feng, Zekun, DiFrancesco, Robin, Morse, Gene D., Ma, Qing
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879810/
https://ncbi.nlm.nih.gov/pubmed/26733388
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg